Complications Associated With Central Venous Access in the NSICU: PICC vs CVC

Milton S. Hershey Medical Center1 site in 1 country152 target enrollmentJuly 13, 2015

ConditionsPICC Central Venous Catheter Central Line Neuro ICU Neuroscience ICU CVC

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: PICC
Sponsor: Milton S. Hershey Medical Center
Enrollment: 152
Locations: 1
Primary Endpoint: Participants With Complications With Central Access Including Insertion
Status: Completed
Last Updated: 8 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The goal of this study is to determine whether Peripherally Inserted Central Catheter or Centrally Inserted Venous Catheters have lower complication rates in the Neuroscience Intensive Care Unit. After admission to the Neuroscience ICU and if they require central access, patients will be randomized to receive a PICC or CVC and complications (such as pneumothorax, deep venous thrombosis, infection, etc.) will be tracked and compared between the two interventions.

Registry

clinicaltrials.gov

Start Date

July 13, 2015

End Date

December 7, 2016

Last Updated

8 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Milton S. Hershey Medical Center

Responsible Party

Principal Investigator

Chris Zacko

Assistant Professor of Neurosurgery

Milton S. Hershey Medical Center

Eligibility Criteria

Inclusion Criteria

•Adult patients admitted to the NSICU, who require central access for the treatment of their illness.

Exclusion Criteria

•Current or recent (within 1 month) diagnosis of bacteremia
•Current or recent (within 1 year with confirmed resolution by imaging) deep venous thrombosis
•Existing central access
•Non-English speaking
•Requirement for emergent central access and unable to obtain consent in an emergency setting

Outcomes

Primary Outcomes

Participants With Complications With Central Access Including Insertion

Time Frame: up to 10 weeks

Aggregation of all complications associated with central access including insertion

Secondary Outcomes

Number of Participants With Deep Venous Thrombosis(up to 10 weeks)
Number of Patients With Complications Related to Insertion(From the time of insertion until first confirmatory chest X-ray)
Number of Participants With a Central Line Associated Blood Stream Infection(up to 10 weeks)